ReviewFrontiers in pharmacology2026

Astragaloside IV in hepatocellular carcinoma: repolarizing macrophages to reprogram the tumor microenvironment.

Peng Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.